Title (fr)

Publication

Application

Priority

GB 9901434 W 19990507

GB 9809839 A 19980509

Abstract (en)

[origin: WO9958679A1] The invention relates to antibodies which bind to the CD23 (FC epsilon RII) type II molecule particularly altered antibodies including antibodies which bind to the CD23 (FC epsilon RII) type II molecule characterised by an affinity constant equal to or greater than 1x10<9> Ka Mo1<-1>, the preparation of such antibodies, pharmaceutical compositions which contain such antibodies and their use in therapy particularly in the treatment of autoimmune and inflammatory disorders.